SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-19-000591
Filing Date
2019-07-31
Accepted
2019-07-31 06:07:08
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q uthr-20190630x10q.htm   iXBRL 10-Q 2491732
2 EXHIBIT 31.1 uthr-20190630ex3111dcdaa.htm EX-31.1 19956
3 EXHIBIT 31.2 uthr-20190630ex31294ef65.htm EX-31.2 19961
4 EXHIBIT 32.1 uthr-20190630ex32101a9ee.htm EX-32.1 9224
5 EXHIBIT 32.2 uthr-20190630ex322343b6d.htm EX-32.2 9242
  Complete submission text file 0001410578-19-000591.txt   10556517

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA uthr-20190630.xsd EX-101.SCH 76119
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE uthr-20190630_cal.xml EX-101.CAL 92750
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE uthr-20190630_def.xml EX-101.DEF 500661
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20190630_lab.xml EX-101.LAB 829726
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20190630_pre.xml EX-101.PRE 620566
11 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20190630x10q_htm.xml XML 1994375
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 19987234
SIC: 2834 Pharmaceutical Preparations